Aptilon Announces Changes to the Board of Directors

    




 MONTREAL, March 28, 2012 /CNW/ - Aptilon Corporation ("Aptilon" or the  "Company") , a leader in online access, engagement and  interaction with physicians and healthcare professionals on behalf of  pharmaceutical and life sciences companies, today announced the  departure of Mr. Robert Boisjoli from the board of directors, effective  immediately. 

 Mr. Boisjoli, who is a member of the board of several public companies,  has informed Aptilon that he wishes to focus his efforts on a limited  number of them. Aptilon thanks him for his contribution to the  Company's activities and wishes him well in his future endeavours. 

 About Aptilon Corporation  

 Aptilon enables pharmaceutical, biotech and medical device companies to  effectively reach, message, connect and interact with US physicians and  healthcare professionals on the Internet and over mobile devices via  multiple access channels. Its innovative service offerings provide  targeted impressions and interactions through: video and mobile  detailing, ReachNet℠ Physician Access Channel, the DMD database and  permission-based email services. Top US pharmaceutical companies and  respected healthcare organizations have adopted Aptilon's solutions to  market to, engage and interact with leading healthcare practitioners.  For more information, visit www.aptilon.com. 

 ReachNet(SM) is a service mark of Aptilon Corporation. 

 Neither TSX Venture Exchange nor its Regulation Services Provider (as  that term is defined in the policies of the TSX Venture Exchange)  accepts responsibility for the adequacy or accuracy of this release. 

Aptilon Corporation


CONTACT:  Mr. Denis MartineauPresidentAptilon [e-mail] 


    

Copyright